Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | WDR5 | P61964 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.36 |
| ▸ | HTR3B | O95264 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19033400 | 0.82 | ALDH1A1 (0.31) | HSD17B10TSHRALDH1A1CYP2A6TDP1 | |
| SCHEMBL14982011 | 0.82 | ALDH1A1 (0.38) | HSD17B10TSHRALDH1A1CYP2A6MAPT | |
| SCHEMBL1938502 | 0.81 | LMNA (0.46) | HSD17B10TSHRALDH1A1CYP2A6TDP1 | |
| SCHEMBL868639 | 0.79 | TSHR (0.52) | HSD17B10TSHRALDH1A1CYP2A6TDP1 | |
| SCHEMBL29716676 | 0.79 | TSHR (0.52) | HSD17B10TSHRALDH1A1CYP2A6TDP1 | |
| SCHEMBL21385140 | 0.77 | TSHR (0.50) | HSD17B10TSHRALDH1A1CYP2A6TDP1 | |
| SCHEMBL31069613 | 0.76 | AURKA (0.47) | HSD17B10TSHRALDH1A1CYP2A6TDP1 | |
| SCHEMBL914483 | 0.74 | ALDH1A1 (0.46) | HSD17B10TSHRALDH1A1CYP2A6TDP1 | |
| SCHEMBL6503106 | 0.74 | ALDH1A1 (0.46) | HSD17B10TSHRALDH1A1CYP2A6TDP1 | |
| SCHEMBL28089496 | 0.74 | DNMT1 (0.40) | HSD17B10TSHRALDH1A1CYP2A6TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020103374-A1 | OPTICALLY ACTIVE QUARTERNARY AMMONIUM SALT WITH AXIAL CHIRALITY, METHOD FOR PRODUCING THEREOF, AND APPLICATION THEREOF FOR ASYMMETRIC SYNTHESIS OF ALPHA-AMINO ACID | NAGASE & CO., LTD (JP) | 2002-08-01 | — | — | US | claimed |
| US-6340753-B1 | CATIONIC QUATERNARY AMMONIUM COMPOUNDS DEHYDROHALOGENATION OF COMPOUNDS TO FORM AMINES | NAGASE & CO., LTD. (JP) | 2002-01-22 | — | — | US | claimed |
| US-9695112-B2 | Method for synthesizing optically active α-amino acid using chiral metal complex comprising axially chiral N-(2-acylaryl)-2-[5,7-dihydro-6H-dibenzo[c,e]azepin-6-yl] acetamide compound and amino acid | HAMARI CHEMICALS, LTD. (JP) | 2017-07-04 | — | — | US | disclosed |
| US-9695112-B2 | Method for synthesizing optically active α-amino acid using chiral metal complex comprising axially chiral N-(2-acylaryl)-2-[5,7-dihydro-6H-dibenzo[c,e]azepin-6-yl] acetamide compound and amino acid | HAMARI CHEMICALS, LTD. (JP) | 2017-07-04 | — | — | US | disclosed |
| US-9688612-B2 | Axially chiral N-(2-acylaryl)-2-[5,7-dihydro-6h-dibenzo[c,e]azepin-6-yl] acetamide compound and chirality interconversion method of a-amino acid using the same | HAMARI CHEMICALS, LTD. (JP) | 2017-06-27 | — | — | US | disclosed |
| US-9688612-B2 | Axially chiral N-(2-acylaryl)-2-[5,7-dihydro-6h-dibenzo[c,e]azepin-6-yl] acetamide compound and chirality interconversion method of a-amino acid using the same | HAMARI CHEMICALS, LTD. (JP) | 2017-06-27 | — | — | US | disclosed |
| US-20160102045-A1 | METHOD FOR SYNTHESIZING OPTICALLY ACTIVE a-AMINO ACID USING CHIRAL METAL COMPLEX COMPRISING AXIALLY CHIRAL N-(2-ACYLARYL)-2-[5,7-DIHYDRO-6H-DIBENZO[c,e]AZEPIN-6-YL] ACETAMIDE COMPOUND AND AMINO ACID | HAMARI CHEMICALS, LTD. (JP) | 2016-04-14 | — | — | US | disclosed |
| US-20160102045-A1 | METHOD FOR SYNTHESIZING OPTICALLY ACTIVE a-AMINO ACID USING CHIRAL METAL COMPLEX COMPRISING AXIALLY CHIRAL N-(2-ACYLARYL)-2-[5,7-DIHYDRO-6H-DIBENZO[c,e]AZEPIN-6-YL] ACETAMIDE COMPOUND AND AMINO ACID | HAMARI CHEMICALS, LTD. (JP) | 2016-04-14 | — | — | US | disclosed |
| EP-3006449-A1 | METHOD FOR SYNTHESIZING OPTICALLY ACTIVE -AMINO ACID USING CHIRAL METAL COMPLEX COMPRISING AXIALLY CHIRAL N-(2-ACYLARYL)-2-[5,7-DIHYDRO-6H-DIBENZO[c,e]AZEPIN-6-YL]ACETAMIDE COMPOUND AND AMINO ACID | Hamari Chemicals, Ltd. (JP) | 2016-04-13 | — | — | EP | disclosed |
| US-20150321994-A1 | AXIALLY CHIRAL N-(2-ACYLARYL)-2-[5,7-DIHYDRO-6H-DIBENZO[c,e]AZEPIN-6-YL] ACETAMIDE COMPOUND AND CHIRALITY INTERCONVERSION METHOD OF ALPHA-AMINO ACID USING THE SAME | Hamari Chemicals, Ltd. 4-29 (JP) | 2015-11-12 | — | — | US | disclosed |
| US-20150321994-A1 | AXIALLY CHIRAL N-(2-ACYLARYL)-2-[5,7-DIHYDRO-6H-DIBENZO[c,e]AZEPIN-6-YL] ACETAMIDE COMPOUND AND CHIRALITY INTERCONVERSION METHOD OF ALPHA-AMINO ACID USING THE SAME | Hamari Chemicals, Ltd. 4-29 (JP) | 2015-11-12 | — | — | US | disclosed |
| US-20090270614-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME | NAGASE & CO., LTD. (JP) | 2009-10-29 | — | — | US | disclosed |
| EP-1870403-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING -AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME | NAGASE & COMPANY, LTD. (JP) | 2007-12-26 | — | — | EP | disclosed |
| EP-1870403-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING -AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME | NAGASE & COMPANY, LTD. (JP) | 2007-12-26 | — | — | EP | disclosed |
| JP-2005015402-A | METHOD FOR PRODUCING OPTICALLY ACTIVE 3,5-DIHYDRO-4H-DINAPHTHO[2,1-c:1',2'-e]AZEPINE AND OXALATE THEREOF | NAGASE & CO LTD | 2005-01-20 | — | — | JP | disclosed |
| JP-2005015402-A | METHOD FOR PRODUCING OPTICALLY ACTIVE 3,5-DIHYDRO-4H-DINAPHTHO[2,1-c:1',2'-e]AZEPINE AND OXALATE THEREOF | NAGASE & CO LTD | 2005-01-20 | — | — | JP | disclosed |
| US-6441231-B1 | SPIRO QUARTERNARY AMMONIUM SALT COMPOUNDS, USED AS PHASE TRANSFER CATALYST FOR STEREOSELECTIVE ALKYLATION | NAGASE & CO., LTD. (JP) | 2002-08-27 | — | — | US | disclosed |
| US-20020103374-A1 | OPTICALLY ACTIVE QUARTERNARY AMMONIUM SALT WITH AXIAL CHIRALITY, METHOD FOR PRODUCING THEREOF, AND APPLICATION THEREOF FOR ASYMMETRIC SYNTHESIS OF ALPHA-AMINO ACID | NAGASE & CO., LTD (JP) | 2002-08-01 | — | — | US | disclosed |
| US-20020065414-A1 | Optically active quarternary ammonium salt with axial chirality, method for producing thereof, and aplication thereof for asymmetric synthesis of alpha-amino acid | NAGASE & CO., LTD. (JP) | 2002-05-30 | — | — | US | disclosed |
| US-6340753-B1 | CATIONIC QUATERNARY AMMONIUM COMPOUNDS DEHYDROHALOGENATION OF COMPOUNDS TO FORM AMINES | NAGASE & CO., LTD. (JP) | 2002-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065414-A1 | Optically active quarternary ammonium salt with axial chirality, method for producing thereof, and aplication thereof for asymmetric synthesis of alpha-amino acid | AADAT, AASDHPPT, BCAT1 | HSD17B10 1801/4885TSHR 4766/4885ALDH1A1 1759/4885 |
| US-20020103374-A1 | OPTICALLY ACTIVE QUARTERNARY AMMONIUM SALT WITH AXIAL CHIRALITY, METHOD FOR PRODUCING THEREOF, AND APPLICATION THEREOF FOR ASYMMETRIC SYNTHESIS OF ALPHA-AMINO ACID | AADAT, BCAT1, BCAT2 | HSD17B10 1549/4885TSHR 4747/4885ALDH1A1 2441/4885 |
| US-20160102045-A1 | METHOD FOR SYNTHESIZING OPTICALLY ACTIVE a-AMINO ACID USING CHIRAL METAL COMPLEX COMPRISING AXIALLY CHIRAL N-(2-ACYLARYL)-2-[5,7-DIHYDRO-6H-DIBENZO[c,e]AZEPIN-6-YL] ACETAMIDE COMPOUND AND AMINO ACID | AADAT, ALDH7A1, BCAT1 | HSD17B10 1583/4885TSHR 4329/4885ALDH1A1 130/4885 |
| US-20090270614-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME | BCAT1, BCAT2, AADAT | HSD17B10 1492/4885TSHR 3260/4885ALDH1A1 837/4885 |
| US-20150321994-A1 | AXIALLY CHIRAL N-(2-ACYLARYL)-2-[5,7-DIHYDRO-6H-DIBENZO[c,e]AZEPIN-6-YL] ACETAMIDE COMPOUND AND CHIRALITY INTERCONVERSION METHOD OF ALPHA-AMINO ACID USING THE SAME | ANPEP, NAAA, NAA15 | HSD17B10 959/4885TSHR 3546/4885ALDH1A1 1672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.